Drug Shortage Report for DEXILANT
Report ID | 143737 |
Drug Identification Number | 02354950 |
Brand name | DEXILANT |
Common or Proper name | Dexlansoprazole delayed release capsules |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXLANSOPRAZOLE |
Strength(s) | 30MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL NASOGASTRIC ORAL NASOGASTRIC |
Packaging size | Bottles of 90's |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-08-05 |
Actual start date | 2021-08-05 |
Estimated end date | 2021-09-10 |
Actual end date | 2021-09-14 |
Shortage status | Resolved |
Updated date | 2021-09-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-09-15 | English | Compare |
v7 | 2021-09-14 | French | Compare |
v6 | 2021-09-14 | English | Compare |
v5 | 2021-08-31 | French | Compare |
v4 | 2021-08-31 | English | Compare |
v3 | 2021-08-06 | English | Compare |
v2 | 2021-08-05 | French | Compare |
v1 | 2021-08-05 | English | Compare |
Showing 1 to 8 of 8